AAI production

There are two direct AAI Implementation Studies and a number of others that are associated with the project (links at the bottom of this page).

2017 Implementation Study assessed the operation of the ELIXIR AAI, including

management of the production and development servers
security related to the hardware and services
customer service point
integration of new Relying Parties to the ELIXIR AAI

The study drew up a plan defining the responsibilities for the primary service provider as well as the transition to secondary service provider for maintenance, update or in case of unannounced downtime. The are also cost estimates, including an estimate of required human resources, for providing AAI services as ELIXIR emerging services in 2018.

This work was in alignment with EXCELERATE WP4.3.1, developing a stepup authentication service as part of the AAI Infrastructure Services Plan. The end report of this study is available here.

The second Implementation Study started in January 2018, working with the Compute and Tools platforms, with goals to:

Continue providing a sustainable service
Develop a strategy to migrate to the Life Science AAI, with new features
Increase the number of relying parties, liaising with the Global Alliance for Genomes and Health (GA4GH).

It is divided into four Workplans:

AAI operations, support and marketing
Migration to LifeScience AAI
Develop and deploy new features
GA4GH Access work stream (tbc. Discovery work stream?)

The results being an increase in the number of users, IDPs and relying serivces. There is an AAI implementation within EOSC-Life and engagement with BBMRI, Euro-Bioimaging, INFRAFRONTIER and Instruct.

Access to sensitive Human data with AAI (rec. May 2018)
Use of AAI for the ELIXIR intranet and access to ELIXIR services (rec. Jan 2017)
Outlining the outcomes from the ELIXIR AAI Pilot launched in 2012 (rec. Mar 2015)
Integration with the de.NBI Cloud (rec. Mar 2018)